title: Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
abstract: Intranasal application of dopamine (IN-DA) has been shown to increase motor activity and to release DA in the ventral (VS) and dorsal striatum (DS) of rats. The aim of the present study was to assess the effects of IN-DA treatment on parameters of DA and excitatory amino acid (EAA) function in prepuberal rats of the Naples high-excitability (NHE) line, an animal model for attention-deficit hyperactivity disorder (ADHD) and normal random bred (NRB) controls. NHE and NRB rats were daily administered IN-DA (0.075, 0.15, 0.30 mg/kg) or vehicle for 15 days from postnatal days 28-42 and subsequently tested in the Làt maze and in the Eight-arm radial Olton maze. Soluble and membrane-trapped L-glutamate (L-Glu) and L-aspartate (L-Asp) levels as well as NMDAR1 subunit protein levels were determined after sacrifice in IN-DA- and vehicle-treated NHE and NRB rats in prefrontal cortex (PFc), DS and VS. Moreover, DA transporter (DAT) protein and tyrosine hydroxylase (TH) levels were assessed in PFc, DS, VS and mesencephalon (MES) and in ventral tegmental area (VTA) and substantia nigra, respectively. In NHE rats, IN-DA (0.30 mg/kg) decreased horizontal activity and increased nonselective attention relative to vehicle, whereas the lower dose (0.15 mg/kg) increased selective spatial attention. In NHE rats, basal levels of soluble EAAs were reduced in PFc and DS relative to NRB controls, while membrane-trapped EAAs were elevated in VS. Moreover, basal NMDAR1 subunit protein levels were increased in PFc, DS and VS relative to NRB controls. In addition, DAT protein levels were elevated in PFc and VS relative to NRB controls. IN-DA led to a number of changes of EAA, NMDAR1 subunit protein, TH and DAT protein levels in PFc, DS, VS, MES and VTA, in both NHE and NRB rats with significant differences between lines. Our findings indicate that the NHE rat model of ADHD may be characterized by (1) prefrontal and striatal DAT hyperfunction, indicative of DA hyperactivty, and (2) prefrontal and striatal NMDA receptor hyperfunction indicative of net EAA hyperactivty. IN-DA had ameliorative effects on activity level, attention, and working memory, which are likely to be associated with DA action at inhibitory D2 autoreceptors, leading to a reduction in striatal DA hyperactivity and, possibly, DA action on striatal EAA levels, resulting in a decrease of striatal EAA hyperfunction (with persistence of prefrontal EAA hyperfunction). Previous studies on IN-DA treatment in rodents have indicated antidepressant, anxiolytic and anti-parkinsonian effects in relation to enhanced central DAergic activity. Our present results strengthen the prospects of potential therapeutic applications of intranasal  DA by indicating an enhancement of selective attention and working memory in a deficit model.
authors.affiliation: Department of Exptl. Med., School of Medicine, Second University of Naples, Naples, Italy.
authors.forename: L A
authors.initials: LA
authors.lastname: Ruocco
authors.forename: C
authors.initials: C
authors.lastname: Treno
authors.forename: U A
authors.initials: UA
authors.lastname: Gironi Carnevale
authors.forename: C
authors.initials: C
authors.lastname: Arra
authors.forename: C
authors.initials: C
authors.lastname: Mattern
authors.forename: J P
authors.initials: JP
authors.lastname: Huston
authors.forename: M A
authors.initials: MA
authors.lastname: de Souza Silva
authors.forename: S
authors.initials: S
authors.lastname: Nikolaus
authors.forename: A
authors.initials: A
authors.lastname: Scorziello
authors.forename: M
authors.initials: M
authors.lastname: Nieddu
authors.forename: G
authors.initials: G
authors.lastname: Boatto
authors.forename: P
authors.initials: P
authors.lastname: Illiano
authors.forename: C
authors.initials: C
authors.lastname: Pagano
authors.forename: A
authors.initials: A
authors.lastname: Tino
authors.forename: A G
authors.initials: AG
authors.lastname: Sadile
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D004195:Disease Models, Animal; D004298:Dopamine / Q000494:pharmacology*; D015259:Dopamine Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012741:Sexual Maturation; D066328:Ventral Striatum / Q000378:metabolism / Q000503:physiopathology
chemical_list: D015259:Dopamine Agents; D004298:Dopamine